Apomorphine
Sponsors
Hospital Universitari Vall d'Hebron Research Institute, Oregon Health and Science University, University Hospital, Toulouse, NeuroHealing Pharmaceuticals Inc., Rambam Health Care Campus
Conditions
AlcoholismBrain InjuryChronic Low Back PainCorticobasal DegenerationHallucinations, VisualHealthyNervous System DiseasesParkinson Disease
Early Phase 1
Phase 2
Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO)
NCT00437177
Start: 2007-01-31End: 2010-06-30Target: 50Updated: 2009-04-29
Low Dose Apomorphine and Parkinsonism
WithdrawnNCT00472355
Start: 2005-10-31End: 2007-05-31Updated: 2018-11-29
Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease
WithdrawnNCT00758368
Start: 2009-03-31End: 2011-06-30Updated: 2018-11-02
Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury
SuspendedNCT00761228
Start: 2010-07-31End: 2018-12-31Target: 76Updated: 2017-03-31
Apomorphine in Parkinson's Disease Patients With Visual Hallucinations
NCT02702076
Start: 2017-05-31End: 2017-12-31Target: 35Updated: 2017-05-03
Phase 3
Phase 4
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
TerminatedNCT02688465
Start: 2016-09-05End: 2017-07-31Updated: 2018-03-26
Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease
CompletedNCT02940912
Start: 2017-01-31End: 2021-04-12Updated: 2024-04-25
The Effects of Apomorphine on Experimental and Clinical Pain in Patients With Chronic Radicular Pain
CompletedNCT02969629
Start: 2012-12-31End: 2014-12-31Updated: 2016-11-22
Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease
CompletedNCT04887467
Start: 2021-09-16End: 2024-07-22Updated: 2025-05-30
Evaluating the impact of Apomorphine injections and pumps on movement and quality of life in Iraqi patients with Parkinson’s disease.
RecruitingPACTR202605760621936
Start: 2026-06-01Target: 30Updated: 2026-08-03
Unknown Phase
Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging Study
CompletedNCT00524914
Start: 2007-09-30End: 2008-03-31Updated: 2008-04-11
Evaluation of the Nonmotor Symptomatology of Parkinsonian Patients Treated With Two Strategies Related to Apomorphine Pump Therapy in French Hospitals
CompletedNCT03693872
Start: 2019-05-15End: 2022-06-02Updated: 2023-11-27
Subcutaneous Apomorphine in the Treatment of Progressive Supranuclear Palsy and Cortico Basal Degeneration (APOPARKA)
CompletedNCT04786158
Start: 2018-12-01End: 2020-07-01Updated: 2021-03-08